EXCELLENT POST- Very Insightful
Most investors here may not be aware of this but the Pharmaceutical Industry as a whole is highly collaborative with other Pharmas BioPharmas within their respective niche markets, and they also do this to expand their niche market.
This explains why a Muti-Billion Dollar Market Cap Big Pharma like Gilead Sciences acquired the small Private Kite BioPharma for $11.9 Billion Cash just to own the only Patent Kite had at the time in 2017, which was (is) an mRNA based Patent for treating various cancers. By doing this Gilead Sciences instantly expanded their niche market.
But other Big Pharmas may acquire or merge with other Pharmas BioPhamas just to obtain the science behind their Patents with the motive that it provides them with the missing pieces of the puzzle for developing their own Patents. If you understand this you have grasped a very big reality of what drives many if not most Big Pharmas.
Case in point, have you ever asked yourself why was a leading scientist at Pfizer, Dr. Rohit Duggal, recruited by RGBP to sit on their Scientific Advisory Board for supporting advancements in development of therapeutics? Dr. Duggal has 17 years experience in drug discovery based at Pfizer as a leader of their cancer stem cell group. He has led development of drug patents that entered clinical trials having experience in translating small molecules into clinical candidates.
This is just one example of what I'm referring to, but Big Pharmas are also know to engage in direct joint venture collaboration that can and does at times led to Merger-Acquisitions.
I have no question in my mind that RGBP is on the same track for what happened to Kite Pharma being bought by Gilead Sciences in 2017 that made them an instant player in the mRNA Vaccine Biotechnology space, and them buying Kite Pharma is what opened the door for that to happen.
Essentially Gilead "bought" that Biotechnology that dramatically strengthened their Market position, and no doubt have expanded on it since then. They wanted to break into the mRNA Vaccine Niche Market that they saw coming on the horizon back in 2017 and they were RIGHT! Now today, it's FRONT CENTER STAGE!
Gilead by acquiring Kite positioned themselves in front of a Multi-Trillion Dollar Global Trend that's absolutely going re-define the Practice of Modern Medicine and that acquisition will prove to make them vast fortunes far beyond what they already have, and any Big Pharma that acquires RGBP will accomplish the same thing and they better HURRY!
So the "take away" here is RGBP is DEFINITELY a Merger-Acquisition/Buy Out candidate like Kite Pharma in 2017, and it wouldn't surprise me at all if Gilead Sciences is a suitor not only for RGBP's mRNA Patent Biotechnology that's near entering clinical trials for cancer treatment, but also to own ALL 24 of RGBP's Patents. This move would dramatically strengthen Gilead's Market position (or any Big Pharma) like non other and this is classic of HOW Big Pharmas go about staying ahead of the competition, i.e. BUY THE BIOTECHNOLOGY then engineer it to the Hilt!
With this I just introduced many of you to the insider World of the Pharmaceutical Industry and how they think and operate.
Later today I will Post my Top 5 Picks of Big Pharmas that might acquire RGBP and I'll give the reasons why....Gilead Sciences is one of them!
Have a great weekend now that we're UP another 17.3% @ 0.04.
Oh, and don't worry about the wicked Naked Short Selling MMs, they will definitely get BLOWN AWAY Post-Pink Current when Massive Buying sets in World Wide! Just look at what Pink Limited did! This definitely was responsible for an increase in buy volume yesterday but not like what's about to happen.
It has already been proven dozens of times MMs can't hold the PPS down when large buy volumes occur and a preview of that we just saw yesterday when we hit 0.04 with nearly a Quarter Billion in Trading Volume to the tune of nearly $10 Million Dollars! This was a great preview of what's coming, only the beginning!
Personally I'm looking for $1.25 short term and $2+ EOY if not Buy Out first!
Stay tuned for my Top 5 Big Pharma "Buy Out" Picks later today!
Be well and prosper...
